Rockefeller Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Rockefeller Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.1K	Sell	3,380 -3,768	-53%	-$16.3K	﹤0.01%	3717
2026 Q1	$20.2K	Buy	7,148 +5,714	+398%	+$19.4K	﹤0.01%	3713
2025 Q4	$4.66K	Buy	+1,434	New	+$4.83K	﹤0.01%	4092
2023 Q1	–	Sell	-721	Closed	-$10K	–	3165
2022 Q4	$10K	Sell	721 -4,879	-87%	-$76.8K	﹤0.01%	3078
2022 Q3	$142K	Buy	+5,600	New	+$141K	﹤0.01%	1810
2022 Q2	–	Sell	-115	Closed	-$4K	–	4289
2022 Q1	$4K	Buy	115 +45	+64%	+$1.51K	﹤0.01%	3426
2021 Q4	$2K	Hold	70	–	–	﹤0.01%	3552
2021 Q3	$3K	Hold	70	–	–	﹤0.01%	3349
2021 Q2	$2K	Buy	+70	New	+$2.71K	﹤0.01%	3257

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Rockefeller Capital Management's MRVI Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Maravai LifeSciences (MRVI) stake by 53% in Q2 2026, selling an estimated $16.3K and leaving 3,380 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3717.

Rockefeller Capital Management first reported a position in MRVI in Q2 2021 and has held it in 9 quarters since. The position peaked at $142K in Q3 2022. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Rockefeller Capital Management held 3,380 shares of Maravai LifeSciences worth $21.1K as of Q2 2026.
Rockefeller Capital Management sold 3,768 Maravai LifeSciences shares in Q2 2026, an estimated $16.3K.
Maravai LifeSciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3717 holding.
Rockefeller Capital Management first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 9 quarters since.
Rockefeller Capital Management's Maravai LifeSciences position peaked at $142K in Q3 2022.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.